The ionization rates of depositing particles in reactive plasma deposition (RPD) were quantitatively investigated using a measurement system composed of a mass-energy analyzer and a Langmuir probe in order to clarify the formation mechanisms of high-quality transparent conductive oxide films. The detection efficiencies of neutral particles and ions in the mass-energy analyzer were calibrated by the Langmuir probe. The species ionization rates were measured during indium tin oxide (ITO) deposition. The ionization rates associated with changes in the deposition chamber pressure were also measured. During ITO deposition, the lower limits of the following ionization rates were determined: indium ionized at a rate of 74-87%, oxygen atoms at 0.5-0.6%, and oxygen molecules at 0.01-0.02%. These rates may increase depending on the pressure in the deposition chamber. This method would also be applicable for measuring general plasma processes.
We elucidated implicate ordering of amorphous Sn-doped In2O3 films grown on glass substrates during the phase transition to polycrystalline by postannealing from room temperature to 300 °C for 55 min. X-ray diffraction with two-dimensional detector revealed the following. First, fine grains are developed. Second, crystallites are grown with (222) preferential orientation associated with growing crystallites along (222) plane. Simultaneously, the alignment between grains is also promoted. Finally, while retaining the alignments among crystallites, long-range ordering was improved within the crystallites. Based on those findings, as a well-defined crystallization temperature, we propose a temperature at which the above-mentioned final stage starts.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.